Actinogen Medical Limited (ATGGF)
OTCMKTS
· Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
Feb 3, 2025, 4:00 PM EST
Actinogen Medical Revenue
In the fiscal year ending June 30, 2024, Actinogen Medical had annual revenue of 9.93M AUD with 103.18% growth. Actinogen Medical had revenue of 9.02M in the half year ending June 30, 2024, with 147.86% growth.
Revenue
9.93M AUD
Revenue Growth
+103.18%
P/S Ratio
n/a
Revenue / Employee
1.66M AUD
Employees
6
Market Cap
60.76M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9.93M | 5.04M | 103.18% |
Jun 30, 2023 | 4.89M | 1.25M | 34.28% |
Jun 30, 2022 | 3.64M | 1.66M | 83.47% |
Jun 30, 2021 | 1.98M | -1.53M | -43.58% |
Jun 30, 2020 | 3.52M | -1.35M | -27.69% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 21.77M |
BioStem Technologies | 210.49M |